Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.

ABSTRACT:

SUBMITTER: Laurenti L 

PROVIDER: S-EPMC5685238 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature